Evidence based cardiology / edited by Salim Yusuf . . . [et al]

Contents
1. Approaches to evaluating evidence
2. A critical appraisal of the cardiovascular history and physical examination
3. Obtaining incremental information from diagnostic tests
4. Finding current best evidence to practice evidence based cardiology
5. Understanding concepts related to the quality of life
6. Understanding concepts related to health economics
7. Introduction to decision analysis
8. Assessing and changing cardiovascular clinical practices
9. Learning from clinical practice
10. Global perspective on cardiovascular disease
11. Tobacco: global burden and community solutions
12. Tobacco and cardiovascular disease: achieving smoking cessation
13. Lipids and cardiovascular disease
14. Use of lipid lowering agents in the prevention of cardiovascular disease
15. Blood pressure and cardiovascular disease
16. Glucose abnormalities and cardiovascular disease: "dysglycemia" as an emerging cardiovascular risk factor
17. Physical activity and exercise in cardiovascular disease prevention and rehabilitation
18. Psychosocial factors in the primary and secondary prevention of coronary heart disease: a systematic review.
19. Emerging approaches in cardiovascular prevention
20. Cost-effectiveness of prevention of cardiovascular disease
21. Estrogens and cardiovascular disease
22. Ethnicity and cardiovascular disease
23. Anti-ischemic drugs
24. Chronic coronary artery disease: coronary artery bypass surgery vs. percutaneous transluminal coronary angioplasty vs. medical therapy
25. Unstable angina
26. Thrombolytic therapy
27. Mechanical reperfusion strategies in patients presenting with acute myocardial infarction
28. Adjunctive antithrombotic therapy for acute myocardial infarction
29. Pain relief, general management and other adjunctive treatments
30. Complications after myocardial infarction
31. An integrated approach to the management of patients after the acute phase of myocardial infarction
32. Atrial fibrillation: antiarrhythmic therapy
33. Atrial fibrillation: antithrombotic therapy
34. Atrial fibrillation: non-pharmacologic therapies
35. Supraventricular tachycardia: drugs vs. ablation
36. Antiarrhythmic therapy in ventricular arrhythmias.
37. Non-pharmacologic therapy for sustained ventricular tachycardia and ventricular fibrillation
38. Impact of pacemakers: when and what kind?
39. Syncope
40. Management of overt heart failure
41. Acute myocarditis and dilated cardiomyopathy
42. Prevention of congestive heart failure and treatment of asymptomatic left ventricular dysfunction
43. Hypertrophic cardiomyopathy
44. Other cardiomyopathies
45. Pericardial disease: an evidence based approach to diagnosis and treatment
46. Rheumatic heart disease: prevention and acute treatment
47. Mitral valve disease
48. Indications for surgery in aortic valve disease
49. Balloon valvuloplasty: aortic valve
50. Balloon valvuloplasty: Mitral valve
51. Valve repair and choice of valves
52. Diagnosis and management of infective endocarditis
53. Antithrombotic therapy after heart valve replacement
54. Pregnancy and heart disease.
55. Coronary intervention: angioplasty, stents, and atherectomy
56. Adjunctive therapy in PTCA
57. Restenosis: etiologies and prevention
58. The prevention of ischemic stroke
59. Venous thromboembolic disease
60. Peripheral vascular disease
61. Stable angina: choice of PTCA vs. CABG vs. drugs
62. Unstable angina: management issues
63. Acute mycocardial infraction : management issues
64. Postmyocardial infarction: routine prophylaxis
65. Postmyocardial infarction risk factor modification: dyslipoproteinemias
66. Peripheral vascular disease with suspect coronary artery disease: management issues
67. Congestive heart failure
68. Atrial fibrillation: management issues
69. Ventricular dysrhythmias: pharmacology vs. non-pharmacology treatment
70. Bradyarrythmias: choice of pacemaker
71. Valvular heart disease: timing of surgery.